Researcher.Life Logo

Journal of Health Economics and Outcomes Research : Impact Factor & More

eISSN: 2327-2236
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Journal of Health Economics and Outcomes Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Columbia Data Analytics, LLC
Language English
Article Processing ChargesUSD 1500
Publication Time10
Editorial Review ProcessDouble blind peer review
General Details
LanguageEnglish
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 10
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble blind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in Journal of Health Economics and Outcomes Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Health Economics and Outcomes Research

Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy
  • 28 Apr 2026
  • Journal of Health Economics and Outcomes Research
Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis
  • 3 Apr 2026
  • Journal of Health Economics and Outcomes Research
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population
  • 19 Mar 2026
  • Journal of Health Economics and Outcomes Research
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population.
  • 19 Mar 2026
  • Journal of health economics and outcomes research
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis
  • 11 Mar 2026
  • Journal of Health Economics and Outcomes Research
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis
  • 11 Mar 2026
  • Journal of Health Economics and Outcomes Research
Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy
  • 28 Apr 2026
  • Journal of Health Economics and Outcomes Research
Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis
  • 3 Apr 2026
  • Journal of Health Economics and Outcomes Research
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population
  • 19 Mar 2026
  • Journal of Health Economics and Outcomes Research
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population.
  • 19 Mar 2026
  • Journal of health economics and outcomes research
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis
  • 11 Mar 2026
  • Journal of Health Economics and Outcomes Research
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis
  • 11 Mar 2026
  • Journal of Health Economics and Outcomes Research

FAQs on Journal of Health Economics and Outcomes Research